Volgen
Geert MOLENBERGHS
Geert MOLENBERGHS
Geverifieerd e-mailadres voor uhasselt.be
Titel
Geciteerd door
Geciteerd door
Jaar
Linear mixed models for longitudinal data
G Verbeke, G Molenberghs, G Verbeke
Linear mixed models in practice: A SAS-oriented approach, 63-153, 1997
69771997
The prevention and treatment of missing data in clinical trials
RJ Little, R D'agostino, ML Cohen, K Dickersin, SS Emerson, JT Farrar, ...
New England Journal of Medicine 367 (14), 1355-1360, 2012
2241*2012
Missing data in clinical studies
G Molenberghs, M Kenward
John Wiley & Sons, 2007
12982007
Longitudinal data analysis
G Fitzmaurice, M Davidian, G Verbeke, G Molenberghs
CRC press, 2008
10332008
Linear mixed models in practice: a SAS-oriented approach
G Verbeke, G Molenberghs
Springer Science & Business Media, 2012
10302012
The dysphonia severity index: an objective measure of vocal quality based on a multiparameter approach
FL Wuyts, MSD Bodt, G Molenberghs, M Remacle, L Heylen, B Millet, ...
Journal of speech, language, and hearing research 43 (3), 796-809, 2000
8692000
The validation of surrogate endpoints in meta-analyses of randomized experiments
M Buyse, G Molenberghs, T Burzykowski, D Renard, H Geys
Biostatistics 1 (1), 49-67, 2000
6792000
Missing data methods in longitudinal studies: a review
JG Ibrahim, G Molenberghs
Test 18 (1), 1-43, 2009
5782009
Analyzing incomplete longitudinal clinical trial data
G Molenberghs, H Thijs, I Jansen, C Beunckens, MG Kenward, ...
Biostatistics 5 (3), 445-464, 2004
5512004
European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997–2009)
N Adriaenssens, S Coenen, A Versporten, A Muller, G Minalu, C Faes, ...
Journal of antimicrobial chemotherapy 66 (suppl_6), vi47-vi56, 2011
5452011
Criteria for the validation of surrogate endpoints in randomized experiments
M Buyse, G Molenberghs
Biometrics, 1014-1029, 1998
5411998
Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis
M Buyse, P Thirion, RW Carlson, T Burzykowski, G Molenberghs, ...
The Lancet 356 (9227), 373-378, 2000
5002000
Handbook of missing data methodology
G Molenberghs, G Fitzmaurice, MG Kenward, A Tsiatis, G Verbeke
CRC Press, 2014
4122014
The evaluation of surrogate endpoints
M Buyse, G Molenberghs
Springer, 2005
4092005
Marginal modeling of correlated ordinal data using a multivariate Plackett distribution
G Molenberghs, E Lesaffre
Journal of the American Statistical Association 89 (426), 633-644, 1994
4051994
The analysis of multivariate longitudinal data: a review
G Verbeke, S Fieuws, G Molenberghs, M Davidian
Statistical methods in medical research 23 (1), 42-59, 2014
3492014
High prevalence of foot diseases in Europe: results of the Achilles Project
T Burzykowski, G Molenberghs, D Abeck, E Haneke, R Hay, A Katsambas, ...
Mycoses 46 (11‐12), 496-505, 2003
3162003
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals …
N Conrad, S Misra, JY Verbakel, G Verbeke, G Molenberghs, PN Taylor, ...
The Lancet 401 (10391), 1878-1890, 2023
3112023
The use of score tests for inference on variance components
G Verbeke, G Molenberghs
Biometrics 59 (2), 254-262, 2003
3062003
Assessing and interpreting treatment effects in longitudinal clinical trials with missing data
CH Mallinckrodt, TM Sanger, S Dubé, DJ DeBrota, G Molenberghs, ...
Biological psychiatry 53 (8), 754-760, 2003
3032003
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20